NIMC
CHRS icon

NWQ Investment Management Company’s Coherus Oncology CHRS Stock Holding History

NWQ Investment Management Company’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4.42M Sell
240,971
-8,082
-3% -$150K 0.2% 112
2020
Q2 		$4.45K Sell
249,053
-229,127
-48% -$3.88M 0.15% 115
2020
Q1 		$7.76M Buy
+478,180
New +$8.83M 0.31% 101

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NWQ Investment Management Company's CHRS Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Coherus Oncology (CHRS) stake by 3.2% in Q3 2020, selling an estimated $150K and leaving 240,971 shares worth $4.42M. The position accounts for 0.2% of the portfolio, ranked #112.

NWQ Investment Management Company first reported a position in CHRS in Q1 2020 and has held it in 3 quarters since. The position peaked at $7.76M in Q1 2020. 201 funds tracked by Wall St. Rank hold CHRS as of Q3 2020.

  • NWQ Investment Management Company held 240,971 shares of Coherus Oncology worth $4.42M as of Q3 2020.
  • NWQ Investment Management Company sold 8,082 Coherus Oncology shares in Q3 2020, an estimated $150K.
  • Coherus Oncology made up 0.2% of NWQ Investment Management Company's portfolio in Q3 2020, its #112 holding.
  • NWQ Investment Management Company first reported a position in Coherus Oncology in Q1 2020 and has held it in 3 quarters since.
  • NWQ Investment Management Company's Coherus Oncology position peaked at $7.76M in Q1 2020.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.